Not Valid for Submission
C91.6 is a non-specific and non-billable diagnosis code code, consider using a code with a higher level of specificity for a diagnosis of prolymphocytic leukemia of t-cell type. The code is not specific and is NOT valid for the year 2021 for the submission of HIPAA-covered transactions. Category or Header define the heading of a category of codes that may be further subdivided by the use of 4th, 5th, 6th or 7th characters.
Specific Coding for Prolymphocytic leukemia of T-cell type
Non-specific codes like C91.6 require more digits to indicate the appropriate level of specificity. Consider using any of the following ICD-10 codes with a higher level of specificity when coding for prolymphocytic leukemia of t-cell type:
Index to Diseases and Injuries
The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code C91.6 are found in the index:
Information for Patients
Chronic Lymphocytic Leukemia
Also called: CLL
Leukemia is cancer of the white blood cells. White blood cells help your body fight infection. Your blood cells form in your bone marrow. In leukemia, the bone marrow produces abnormal white blood cells. These cells crowd out the healthy blood cells, making it hard for blood to do its work. In chronic lymphocytic leukemia (CLL), there are too many lymphocytes, a type of white blood cell.
CLL is the second most common type of leukemia in adults. It often occurs during or after middle age, and is rare in children.
Usually CLL does not cause any symptoms. If you have symptoms, they may include
- Painless swelling of the lymph nodes in the neck, underarm, stomach, or groin
- Pain or a feeling of fullness below the ribs
- Fever and infection
- Weight loss
Tests that examine the blood, bone marrow, and lymph nodes diagnose CLL. Your doctor may choose to just monitor you until symptoms appear or change. Treatments include radiation therapy, chemotherapy, surgery to remove the spleen, and targeted therapy. Targeted therapy uses substances that attack cancer cells or block the growth and spread of cancer cells.
NIH: National Cancer Institute
- After chemotherapy - discharge (Medical Encyclopedia)
- B-cell leukemia/lymphoma panel (Medical Encyclopedia)
- Bone marrow transplant (Medical Encyclopedia)
- Bone marrow transplant - discharge (Medical Encyclopedia)
- Chronic lymphocytic leukemia (CLL) (Medical Encyclopedia)
[Learn More in MedlinePlus]